Ad
related to: pfizer's covid-19- Schedule A Vaccine
Book A Vaccine Appointment
Today At A Location Near You.
- Take Eligibility Quiz
Check Your Eligibility For Vaccines
That May Help Protect You.
- Pneumococcal Pneumonia
Visit VaxAssist.com To
See If You Are Eligible.
- Questions About Cost?
Visit To Find More Information
On COVID-19 Vaccination Costs.
- Schedule A Vaccine
Search results
Pfizer's Options Frenzy: What You Need to Know - Pfizer (NYSE:PFE)
Benzinga· 1 day agoInsights into Volume & Open Interest Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Pfizer ...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 12 hours agoQ1 Earnings & Sales Top, EPS Guidance Raised Pfizer’s first-quarter results were strong as it beat...
Moderna's RSV vaccine for older adults approved
Axios· 8 hours agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever
Motley Fool via Yahoo Finance· 7 days agoHowever, Pfizer's performance in 2021 and 2022 was always going to be a tough act to follow....
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 17 hours agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 13 hours agoAccording to the data, 61% of patients taking Lorbrena had no disease progression after five years,...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 5 hours agoLorbrena, like Pfizer's Xalkori, is designed to treat cancer with a mutation of a specific gene...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 11 hours agoFood and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any mRNA shot...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 6 hours ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
How Much Will Pfizer Pay Out in Dividends This Year?
Motley Fool via Yahoo Finance· 6 days agoTotal sales have declined, but if we ignore COVID-19 products and currency exchange, first-quarter revenue rose 11% year over year. Now that the worst &...